Replies to post #2575 on Acadia Pharmaceuticals Inc. (ACAD)

[2014shelby]

ACAD still struggling. $30-40 and back again.

[2014shelby]

Maybe PFE will have interest in ACAD given the announcement today?

Seeking alpha:

• Pfizer (NYSE:PFE) is giving up on discovering new drugs for Alzheimer's and Parkinson's disease, abandoning costly efforts to find effective treatments for the disorders.
• The cutback will result in 300 layoffs over the next several months.
• "This was an exercise to reallocate [spending] across our portfolio, to focus on those areas where our pipeline, and our scientific expertise, is strongest," Pfizer said in a statement.